TN
Thirthagiri Nedunchezhiyan
About Thirthagiri Nedunchezhiyan
Data last updated:
Thirthagiri Nedunchezhiyan has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Rivisa Pharmaceuticals (Opc) Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rivisa Pharmaceuticals (Opc) Private Limited at ₹0.06 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rivisa Pharmaceuticals (Opc) Private Limited U74999TZ2017OPC028960 | Director | 19 May 2017 | 2017 | ₹0.06 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thirthagiri Nedunchezhiyan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thirthagiri Nedunchezhiyan
Thirthagiri Nedunchezhiyan has 9 years in corporate governance. Holds Director role. Currently with 1 company, including Rivisa Pharmaceuticals (Opc) Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Rivisa Pharmaceuticals (Opc) Private Limited at ₹0.06 Cr (FY 2025).
Thirthagiri Nedunchezhiyan is associated with 1 company as Director, including Rivisa Pharmaceuticals (Opc) Private Limited (₹0.06 Cr).
Thirthagiri Nedunchezhiyan has expertise in General Business.
Thirthagiri Nedunchezhiyan has 9 years in corporate governance.
By reported revenue, the largest current company of Thirthagiri Nedunchezhiyan is Rivisa Pharmaceuticals (Opc) Private Limited, with revenue of ₹0.06 Cr (FY 2025).
Thirthagiri Nedunchezhiyan currently holds positions at 1 company: Rivisa Pharmaceuticals (Opc) Private Limited (₹0.06 Cr).